✦ LIBER ✦

Third-line chemotherapy in platinum- and paclitaxel-resistant ovarian, fallopian tube, and primary peritoneal carcinoma patients

✍ Scribed by S. Tangjitgamol; H. T. See; S. Manusirivithaya; C. F. Levenback; D. M. Gershenson; J. J. Kavanagh

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Second-line chemotherapy with docetaxel

✍ Takahide Arimoto, Shunsuke Nakagawa, Katsutoshi Oda, Kei Kawana, Toshiharu Yasug 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 104 KB

Topotecan in patients with BRCA-associat

✍ David M. Hyman; Qin Zhou; Angela G. Arnold; Rachel N. Grisham; Alexia Iasonos; N 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 299 KB

Chemotherapy time interval and developme

✍ Koji Matsuo; Michele L. Eno; Dwight D. Im; Neil B. Rosenshein 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 208 KB

Usefulness of third-line chemotherapy fo

✍ Shin Nishio; Noriyuki Katsumata; Koji Matsumoto; Hiroshi Tanabe; Kan Yonemori; T 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 264 KB

Phase 2 trial of carboplatin, paclitaxel

✍ Pedro F Escobar; Maurie Markman; Peter Rose; Kristine Zanotti; Kenneth Webster; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 97 KB

Thrombocytopenia associated with second-

✍ Maurie Markman; Jon Markman; Kenneth Webster; Kristine Zanotti; Barbara Kulp; Ge 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 164 KB